These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa. Tartaglia G, Cao Q, Padron ZM, South AP. Int J Mol Sci; 2021 May 12; 22(10):. PubMed ID: 34065916 [Abstract] [Full Text] [Related]
3. Role of transforming growth factor-β1 in recessive dystrophic epidermolysis bullosa squamous cell carcinoma. Twaroski K, Chen W, Pickett-Leonard M, Tolar J. Exp Dermatol; 2021 May 12; 30(5):664-675. PubMed ID: 33595864 [Abstract] [Full Text] [Related]
4. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa. Kim M, Murrell DF. Eur J Dermatol; 2015 Apr 12; 25 Suppl 1():30-2. PubMed ID: 26083672 [Abstract] [Full Text] [Related]
12. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Santucci C, Alexandru M, Chen X, Mellerio JE, Karagiannis SN, Jacków-Malinowska J. Hum Immunol; 2024 May 15; 85(3):110805. PubMed ID: 38703415 [Abstract] [Full Text] [Related]
13. High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion. Pourreyron C, Chen M, McGrath JA, Salas-Alanis JC, South AP, Leigh IM. Br J Dermatol; 2014 Jun 15; 170(6):1256-65. PubMed ID: 24641191 [Abstract] [Full Text] [Related]
15. A novel homozygous splice site mutation in COL7A1 in a Chinese patient with severe recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Huang L, Wong YP, Burd A. Int J Dermatol; 2011 Jan 15; 50(1):52-6. PubMed ID: 21182502 [Abstract] [Full Text] [Related]
17. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Ng YZ, Pourreyron C, Salas-Alanis JC, Dayal JH, Cepeda-Valdes R, Yan W, Wright S, Chen M, Fine JD, Hogg FJ, McGrath JA, Murrell DF, Leigh IM, Lane EB, South AP. Cancer Res; 2012 Jul 15; 72(14):3522-34. PubMed ID: 22564523 [Abstract] [Full Text] [Related]
18. Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts. Atanasova VS, Russell RJ, Webster TG, Cao Q, Agarwal P, Lim YZ, Krishnan S, Fuentes I, Guttmann-Gruber C, McGrath JA, Salas-Alanis JC, Fertala A, South AP. J Invest Dermatol; 2019 Jul 15; 139(7):1497-1505.e5. PubMed ID: 30684555 [Abstract] [Full Text] [Related]
19. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity. Odorisio T, Di Salvio M, Orecchia A, Di Zenzo G, Piccinni E, Cianfarani F, Travaglione A, Uva P, Bellei B, Conti A, Zambruno G, Castiglia D. Hum Mol Genet; 2014 Aug 01; 23(15):3907-22. PubMed ID: 24599399 [Abstract] [Full Text] [Related]
20. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas. Föll MC, Fahrner M, Gretzmeier C, Thoma K, Biniossek ML, Kiritsi D, Meiss F, Schilling O, Nyström A, Kern JS. Matrix Biol; 2018 Mar 01; 66():1-21. PubMed ID: 29158163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]